Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) Q1 2018 Earnings Conference Call - Final Transcript
May 10, 2018 • 08:30 am ET
continue to build significant cash, are minimally levered and have the ability to add to our growth through product or company acquisitions. And as we have always done, we will continue to manage our cash prudently so that we can invest in activities that maximize value for shareholders.
With that, I'd like to thank you for your continued support and open the call for questions. Operator, please go ahead and open the line for questions.